Antidepressant efficacy and side-effect burden: a quick guide for clinicians
Prescribing of antidepressant treatment (ADT) for major depressive disorder (MDD) has increased in quantity and popularity over the last two decades. This is likely due to the approval of safer medications, better education of clinicians and their patients, direct-to-consumer marketing practices, an...
Main Authors: | Daniel Santarsieri, Thomas L Schwartz |
---|---|
Format: | Article |
Language: | English |
Published: |
BioExcel Publishing Ltd
2015-10-01
|
Series: | Drugs in Context |
Subjects: | |
Online Access: | http://www.drugsincontext.com/antidepressant-efficacy-and-side-effect-burden-a-quick-guide-for-clinicians/ |
Similar Items
-
Antidepressants in epilepsy
by: M.M. Gutiérrez Rodríguez, et al.
Published: (2022-06-01) -
Pharmacogenomic biomarkers as source of evidence of the effectiveness and safety of antidepressant therapy
by: Catarina Correia, et al.
Published: (2022-08-01) -
Venous Thromboembolism Risk With Antidepressants: Driven by Disease or Drugs?
by: Brian R. Branchford
Published: (2017-05-01) -
Watchful waiting for depression using depathologization, advice and shared decision making
by: Milutin Kostic, et al.
Published: (2024-04-01) -
Relevant issues in pharmacotherapy of psycho-cutaneous disorders
by: Sreyoshi Ghosh, et al.
Published: (2013-01-01)